Global Health Science Institute
Public records show a registered, tax-exempt organization in good standing.
What it says it does
With YOUR partnership, our mission is IMPROVING HUMAN HEALTH IMPACT THROUGH LIMITED PIONEERING OPPORTUNITIES within the meaning Section 501(c)(3) of the I.R.C. This encompasses, but not all-inclusive, developing tools within the medical, technology, engineering industries...all done with no administrative overhead, no laboratory animals, or no radioactive material uses. This also involves Pilot Studies. "DIFFERENT EYES SEE DIFFERENT THINGS, SO ALIGN WITH US TODAY!"
- Income
- $418,416
- Spending
- $418,416
- Spent on programs
- 100%
- Reserves
- 0 months of spending
- Largest source of income
- donations and private grants, 90%
- Employees
- 0
- Volunteers
- 4
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Fair: 58 out of 100. Higher than 18% of charities in its peer group (diseases, $250k to $1m).
Reserves
4 of 35Spendable reserves would cover 0.0 months of spending.
Living within its means
12 of 15Income exceeded spending by 0% of income.
Income trend
15 of 15Income rose 43% on the year before.
Spending floor
15 of 15100% of spending went to programs and raising each dollar of donations cost 0 cents.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Good: 80 out of 100. Higher than 55% of charities in its peer group (diseases, $250k to $1m).
Independent board
25 of 259 of 9 voting board members are independent.
Conflict of interest policy
15 of 15Has a written conflict of interest policy.
Whistleblower policy
8 of 8Has a written whistleblower policy.
Record keeping policy
7 of 7Has a written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
0 of 10Did not give the board a copy of this return before filing it.
Independent check of accounts
6 of 15Its accounts were not audited or reviewed by an independent accountant.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (3)
- $418,416 spent. CORE IMPACTS FOR THE YEAR 2025 Index of Major Program Accomplishments Overview While we secure capital to construct our 7,500 sq. ft. biomedical and engineering development facility, we have focused on translational science and engineering: publishing, building working biomedical tools, and developing human-relevant research systems using microcontrollers, 3D modeling, and AI technologies. Our organization designs and builds human-centered biomedical tools that replace fragile, high-cost laboratory systems and reduce reliance on animal models. We emphasize practical innovation - technologies that can be manufactured, repaired, and adapted locally using microcontrollers, 3D-printed components, laser-cut materials, and simulation-driven design. This allows us to build affordable, reproducible tools aligned with real-world patient care - not just theoretical laboratory success. A. Major Cancer Publication - Advancing Understanding in RAS-Driven Disease In collaboration with researchers from the University of Texas-El Paso and New Mexico State University, our team published a 39-page biomedical journal article in Biology (2025, Vol. 14, Issue 8, Article 936): "Research Challenges in Stage III and IV RAS-Associated Cancers: A Narrative Review of the Complexities and Functions of the Family of RAS Genes and Ras Proteins in Housekeeping and Tumorigenesis." The core message is simple and sobering: after more than 50 years of global research into RAS-driven cancers, late-stage patients still lack reliable therapeutic options. This paper identifies the major biological and translational barriers preventing progress and calls for practical, implementation-focused innovation rather than incremental repetition of prior work. Autodesk Inventor Pro was used to support scientific visualization and pathway modeling. B. Human Adaptive Response Emulator (HARE) We began developing the Human Adaptive Response Emulator (HARE) - a human-relevant biology platform designed to generate decision-quality data before medical technologies reach clinical trials. Many products perform well in animal models but fail in humans because: * animal disease models do not faithfully replicate human disease * toxicity responses differ across species * animal immune systems provide misleading safety signals HARE addresses these failure points directly by operating in human-derived cells and human-relevant signaling environments, thereby evaluating disease behavior, toxicity, and immune response in systems that reflect real human biology. This work advances our mission to develop ethical, efficient, and patient-centered biomedical tools and to help reduce clinical trial failures driven by animal-based inference. C. Autonomous UV-C Floor Decontamination System (AUF-DS) We are developing an autonomous UV-C floor-decontamination robot for healthcare, laboratory, and community environments where biological contamination risk is high but staffing and resources are limited. Traditional cleaning depends on labor-intensive processes, chemical disinfectants, and inconsistent coverage. Our goal is to design a cost-efficient, microcontroller-based platform that autonomously navigates indoor spaces and delivers controlled UV-C exposure to floor surfaces - reducing microbial burden without chemical residue. The system is being designed using open-architecture principles, so nonprofit hospitals, public laboratories, and educational institutions can reproduce or adapt the technology without proprietary lock-in or high licensing costs. During this reporting period, we focused on concept design, navigation strategy, safety shielding, and controlled UV-C exposure management. Future phases will include validation testing and publication of implementation guidance to support adoption in resource-limited environments. D. Plexiglass Isotope Column Holders We designed and fabricated precision plexiglass isotope-column holders to improve the stability and reproducibility of column-based separation systems used in biomedical workflows such as protein purification, metabolite isolation, and biomarker preparation. By improving column alignment and reducing vibration, these holders support more stable separations and reproducible analytical results. E. Triton XT 3D-Printed Filament Holders We engineered and produced 3D-printed filament holders for the Triton XT instrument to ensure stable handling of temperature-sensitive and specialty materials used in biomedical and analytical workflows. This supports the future fabrication of biosensors, scaffold materials, and microfluidic research tools, while reducing waste and maintaining print integrity. F. Microcontroller-Based Water Bath Temperature System We designed a microcontroller-driven water-bath temperature monitoring and control system to replace a failed probe in a Chemical Engineering cell-culture laboratory - restoring functionality at a fraction of commercial replacement costs. G. Microcontroller-Based Vibration Analysis Device We developed a portable vibration-analysis system to compare pump performance for small analytical devices in a Biochemistry lab - supporting more reliable sample handling and equipment optimization. H. NOVA STORM Field Safety Device The NOVA STORM Field Safety Device is a fully functional prototype designed to perform rapid, affordable chemical analysis in hazardous civilian and military environments. We are seeking one-time support solely for patent protection - attorney and filing costs only - with no funds retained by the Institute. Once protected, the device can advance responsibly in partnership with organizations such as NASA, NATO, and the Department of Defense, moving toward deployment for frontline and humanitarian applications. I. SpectraSense DNA SpectraSense DNA is a system under development to visualize DNA without carcinogenic or mutagenic dyes traditionally required in gel analysis. Blueprints were finalized in 2025. Prototype construction begins in 2026, follow
- N/A
- N/A
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated November 6, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2025.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since April 2012.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated November 4, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.